Skip to main content
Erschienen in: Journal of Clinical Immunology 2/2009

01.03.2009

First Report of Clinical, Functional, and Molecular Investigation of Chronic Granulomatous Disease in Nine Jordanian Families

verfasst von: Faris G. Bakri, Cécile Martel, Najwa Khuri-Bulos, Azmi Mahafzah, Mohammad S. El-Khateeb, Adel M. Al-Wahadneh, Wail A. Hayajneh, Hanan A. Hamamy, Elisabeth Maquet, Michelle Molin, Marie José Stasia

Erschienen in: Journal of Clinical Immunology | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Chronic granulomatous disease is a rare inherited immunodeficiency syndrome caused by mutations in four genes encoding essential nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex components.

Material and methods

Clinical, functional, and molecular investigations were conducted in 15 Jordanian CGD patients from nine families.

Results and Discussion

Fourteen patients were children of consanguineous parents and suffered from autosomal recessive (AR) CGD forms with mutations in the CYBA, NCF1, and NCF2 genes encoding p22phox, p47phox, and p67phox proteins, except for one patient in whom the mutation’s location was not found. One patient had an extremely rare X+CGD subtype resulting from a novel missense mutation (G1234C) in exon 10 of CYBB. We found a genetic heterogeneity in the Jordanian families with a high frequency of rare ARCGD, probably because consanguineous marriages are common in Jordan. No clear correlation between the severity of the clinical symptoms and the CGD types could be established.
Literatur
1.
2.
Zurück zum Zitat Stasia MJ, Li XJ. Genetic and immunopathology of chronic granulomatous disease. Semin Immunopathol 2008;30(3):209–35.PubMedCrossRef Stasia MJ, Li XJ. Genetic and immunopathology of chronic granulomatous disease. Semin Immunopathol 2008;30(3):209–35.PubMedCrossRef
5.
Zurück zum Zitat Azuma H, Oomi K, Sasak I, Kawabata T, Sakaino S, Koyano T, et al. A new mutation in exon 12 of the gp91-phox gene leading to cytochrome b-positive X-linked chronic granulomatous disease. Blood 1995;85:3274–7.PubMed Azuma H, Oomi K, Sasak I, Kawabata T, Sakaino S, Koyano T, et al. A new mutation in exon 12 of the gp91-phox gene leading to cytochrome b-positive X-linked chronic granulomatous disease. Blood 1995;85:3274–7.PubMed
8.
Zurück zum Zitat Tsuda M, Kaneda M, Sakiyama T, Inana I, Owada M, Kiryu C, et al. A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease. Hum Genet 1998;103:377–81. doi:10.1007/s004390050836.PubMedCrossRef Tsuda M, Kaneda M, Sakiyama T, Inana I, Owada M, Kiryu C, et al. A novel mutation at a probable heme-binding ligand in neutrophil cytochrome b558 in atypical X-linked chronic granulomatous disease. Hum Genet 1998;103:377–81. doi:10.​1007/​s004390050836.PubMedCrossRef
9.
Zurück zum Zitat Yu L, Cross AR, Zhen L, Dinauer MC. Functional analysis of NADPH oxidase in granulocytic cells expressing a Δ488-497 pg91-phox deletion mutant. Blood 1999;94:2497–504.PubMed Yu L, Cross AR, Zhen L, Dinauer MC. Functional analysis of NADPH oxidase in granulocytic cells expressing a Δ488-497 pg91-phox deletion mutant. Blood 1999;94:2497–504.PubMed
10.
Zurück zum Zitat Leusen JH, Meischl C, Eppink MHM, Hilarius PM, de Boer M, Weening RS, et al. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly. Blood 2000;95:666–73.PubMed Leusen JH, Meischl C, Eppink MHM, Hilarius PM, de Boer M, Weening RS, et al. Four novel mutations in the gene encoding gp91-phox of human NADPH oxidase: consequences for oxidase assembly. Blood 2000;95:666–73.PubMed
11.
Zurück zum Zitat Stasia MJ, Lardy B, Maturana A, Rousseau P, Martel C, Bordigoni P, et al. Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the gp91-phox-cytosolique C-terminal tail. Biochim Biophys Acta 2002;1586:316–30.PubMed Stasia MJ, Lardy B, Maturana A, Rousseau P, Martel C, Bordigoni P, et al. Molecular and functional characterization of a new X-linked chronic granulomatous disease variant (X91+) case with a double missense mutation in the gp91-phox-cytosolique C-terminal tail. Biochim Biophys Acta 2002;1586:316–30.PubMed
12.
Zurück zum Zitat Bionda C, Li XJ, van Bruggen R, Eppink M, Roos D, Morel F, et al. Functional analysis of two-amino acid substitution in gp91phox in a patient with X-linked flavocytochrome-b 558-positive chronic granulomatous disease by means of transgenic PLB-985 cells. Hum Genet 2004;115:418–27. doi:10.1007/s00439-004-1173-z.PubMedCrossRef Bionda C, Li XJ, van Bruggen R, Eppink M, Roos D, Morel F, et al. Functional analysis of two-amino acid substitution in gp91phox in a patient with X-linked flavocytochrome-b 558-positive chronic granulomatous disease by means of transgenic PLB-985 cells. Hum Genet 2004;115:418–27. doi:10.​1007/​s00439-004-1173-z.PubMedCrossRef
13.
Zurück zum Zitat Li XJ, Fieschi F, Paclet MH, Grunwald D, Campion Y, Gaudin P, et al. Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly. J Leukoc Biol 2007;81:238–49. doi:10.1189/jlb.0905541.PubMedCrossRef Li XJ, Fieschi F, Paclet MH, Grunwald D, Campion Y, Gaudin P, et al. Leu505 of Nox2 is crucial for optimal p67phox-dependent activation of the flavocytochrome b558 during phagocytic NADPH oxidase assembly. J Leukoc Biol 2007;81:238–49. doi:10.​1189/​jlb.​0905541.PubMedCrossRef
14.
Zurück zum Zitat Stasia MJ. The X+ chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation. Med Sci (Paris) 2007;23:526–32. (Review). Stasia MJ. The X+ chronic granulomatous disease as a fabulous model to study the NADPH oxidase complex activation. Med Sci (Paris) 2007;23:526–32. (Review).
15.
Zurück zum Zitat Roos D, De Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996;87:1663–81.PubMed Roos D, De Boer M, Kuribayashi F, Meischl C, Weening RS, Segal AW, et al. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 1996;87:1663–81.PubMed
16.
Zurück zum Zitat Rae J, Newburger PE, Dinauer MC. X-linked chronic granulomatous disease:mutations in the CYBB gene encoding the gp91-phox component of respiratory burst oxidase. Am J Hum Genet 1998;62:1320–31. doi:10.1086/301874.PubMedCrossRef Rae J, Newburger PE, Dinauer MC. X-linked chronic granulomatous disease:mutations in the CYBB gene encoding the gp91-phox component of respiratory burst oxidase. Am J Hum Genet 1998;62:1320–31. doi:10.​1086/​301874.PubMedCrossRef
17.
Zurück zum Zitat Noack D, Rae J, Cross AR, Ellis BA, Newburger PE, Curnutte JT, et al. Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox: mutations not arising in the NCF-1 pseudogenes. Blood 2001;97:305–11. doi:10.1182/blood.V97.1.305.PubMedCrossRef Noack D, Rae J, Cross AR, Ellis BA, Newburger PE, Curnutte JT, et al. Autosomal recessive chronic granulomatous disease caused by defects in NCF-1, the gene encoding the phagocyte p47-phox: mutations not arising in the NCF-1 pseudogenes. Blood 2001;97:305–11. doi:10.​1182/​blood.​V97.​1.​305.PubMedCrossRef
18.
Zurück zum Zitat Roos D, de Boer M, Köker MY, Dekker J, Singh-Gupta V, Ahlin A, et al. Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase. Hum Mutat 1996;27:1218–29. doi:10.1002/humu.20413.CrossRef Roos D, de Boer M, Köker MY, Dekker J, Singh-Gupta V, Ahlin A, et al. Chronic granulomatous disease caused by mutations other than the common GT deletion in NCF1, the gene encoding the p47phox component of the phagocyte NADPH oxidase. Hum Mutat 1996;27:1218–29. doi:10.​1002/​humu.​20413.CrossRef
20.
Zurück zum Zitat Cohen-Tanugi L, Morel F, Pilloud-Dagher MC, Seigneurin JM, François P, Bost M, et al. Activation of O2 - generating oxidase in heterologous cell-free system derived from Epstein-Barr-virus-transformed human B lymphocytes and bovine neutrophils. Eur J Biochem. 1991;202:649–55. doi:10.1111/j.1432-1033.1991.tb16419.x.PubMedCrossRef Cohen-Tanugi L, Morel F, Pilloud-Dagher MC, Seigneurin JM, François P, Bost M, et al. Activation of O2 - generating oxidase in heterologous cell-free system derived from Epstein-Barr-virus-transformed human B lymphocytes and bovine neutrophils. Eur J Biochem. 1991;202:649–55. doi:10.​1111/​j.​1432-1033.​1991.​tb16419.​x.PubMedCrossRef
22.
Zurück zum Zitat Batot G, Paclet MH, Doussière J, Vergnaud S, Martel C, Vignais PV, et al. Biochemical and immunochemical properties of B lymphocyte cytochrome b 558 . Biochim Biophys Acta. 1998;1406:188–202.PubMed Batot G, Paclet MH, Doussière J, Vergnaud S, Martel C, Vignais PV, et al. Biochemical and immunochemical properties of B lymphocyte cytochrome b 558 . Biochim Biophys Acta. 1998;1406:188–202.PubMed
25.
26.
Zurück zum Zitat Verhoeven AJ, Bolscher GJM, Meerhof L, van Zwieten R, Keijer J, Weening RS, et al. Characterization of two monoclonal antibodies against cytochrome b 558 of human neutrophils. Blood 1989;73:1686–94.PubMed Verhoeven AJ, Bolscher GJM, Meerhof L, van Zwieten R, Keijer J, Weening RS, et al. Characterization of two monoclonal antibodies against cytochrome b 558 of human neutrophils. Blood 1989;73:1686–94.PubMed
31.
Zurück zum Zitat de Boer M, Singh V, Dekker J, Di Rocco M, Goldblatt D, Roos D. Prenatal diagnosis in two families with autosomal, p47phox-deficient chronic granulomatous disease due to a novel point mutation in NCF1. Prenat Diagn. 2002;22:235–40. doi:10.1002/pd.296.PubMedCrossRef de Boer M, Singh V, Dekker J, Di Rocco M, Goldblatt D, Roos D. Prenatal diagnosis in two families with autosomal, p47phox-deficient chronic granulomatous disease due to a novel point mutation in NCF1. Prenat Diagn. 2002;22:235–40. doi:10.​1002/​pd.​296.PubMedCrossRef
32.
Zurück zum Zitat Patiño PJ, Rae J, Noack D, Erickson R, Ding J, de Olarte DG, et al. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox. Blood 1999;94:2505–14.PubMed Patiño PJ, Rae J, Noack D, Erickson R, Ding J, de Olarte DG, et al. Molecular characterization of autosomal recessive chronic granulomatous disease caused by a defect of the nicotinamide adenine dinucleotide phosphate (reduced form) oxidase component p67-phox. Blood 1999;94:2505–14.PubMed
33.
Zurück zum Zitat El Kares R, Barbouche MR, Elloumi-Zghal H, Bejaoui M, Chemli J, Mellouli F, et al. Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia. J Hum Genet. 2006;51:887–95. doi:10.1007/s10038-006-0039-8.PubMedCrossRef El Kares R, Barbouche MR, Elloumi-Zghal H, Bejaoui M, Chemli J, Mellouli F, et al. Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia. J Hum Genet. 2006;51:887–95. doi:10.​1007/​s10038-006-0039-8.PubMedCrossRef
34.
Zurück zum Zitat Ishibashi F, Nunoi H, Endo F, Matsuda I, Kanegasaki F. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency. Hum Genet. 2000;106:473–81. doi:10.1007/s004390000288.PubMedCrossRef Ishibashi F, Nunoi H, Endo F, Matsuda I, Kanegasaki F. Statistical and mutational analysis of chronic granulomatous disease in Japan with special reference to gp91-phox and p22-phox deficiency. Hum Genet. 2000;106:473–81. doi:10.​1007/​s004390000288.PubMedCrossRef
35.
Zurück zum Zitat Cross AR, Noack D, Rae J, Curnutte JT, Heyworth PG. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (first update). Blood Cells Mol Dis. 2000;26:561–5. doi:10.1006/bcmd.2000.0333.PubMedCrossRef Cross AR, Noack D, Rae J, Curnutte JT, Heyworth PG. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (first update). Blood Cells Mol Dis. 2000;26:561–5. doi:10.​1006/​bcmd.​2000.​0333.PubMedCrossRef
37.
Zurück zum Zitat Hamamy HA, Masri AT, Al-Hadidy AM, Ajlouni KM. Consanguinity and genetic disorders. Profile from Jordan. Saudi Med J. 2007;28:1015–7.PubMed Hamamy HA, Masri AT, Al-Hadidy AM, Ajlouni KM. Consanguinity and genetic disorders. Profile from Jordan. Saudi Med J. 2007;28:1015–7.PubMed
39.
Zurück zum Zitat Krawczak M, Cooper DN. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet. 1991;86:425–41. doi:10.1007/BF00194629.PubMedCrossRef Krawczak M, Cooper DN. Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment. Hum Genet. 1991;86:425–41. doi:10.​1007/​BF00194629.PubMedCrossRef
40.
Zurück zum Zitat Leusen JH, Bolscher BG, Hilarius PM, Weening RS, Kaulfersch W, Seger RA, et al. 156Pro–>Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Exp Med. 1996;180:2329–34. doi:10.1084/jem.180.6.2329.CrossRef Leusen JH, Bolscher BG, Hilarius PM, Weening RS, Kaulfersch W, Seger RA, et al. 156Pro–>Gln substitution in the light chain of cytochrome b558 of the human NADPH oxidase (p22-phox) leads to defective translocation of the cytosolic proteins p47-phox and p67-phox. J Exp Med. 1996;180:2329–34. doi:10.​1084/​jem.​180.​6.​2329.CrossRef
41.
Zurück zum Zitat Dinauer MC, Pierce EA, Bruns GAP, Curnutte JT, Orkin SH. Human neutrophil cytochrome b light chain (p22phox): gene structure, chromosomal localization and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest. 1990;86:1729–37. doi:10.1172/JCI114898.PubMedCrossRef Dinauer MC, Pierce EA, Bruns GAP, Curnutte JT, Orkin SH. Human neutrophil cytochrome b light chain (p22phox): gene structure, chromosomal localization and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest. 1990;86:1729–37. doi:10.​1172/​JCI114898.PubMedCrossRef
43.
Zurück zum Zitat Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 2007;45:675–83. doi:10.1002/hep.21524.PubMedCrossRef Hussain N, Feld JJ, Kleiner DE, Hoofnagle JH, Garcia-Eulate R, Ahlawat S, et al. Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology 2007;45:675–83. doi:10.​1002/​hep.​21524.PubMedCrossRef
44.
Zurück zum Zitat Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. IPINET. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol. 2008;126:155–64. doi:10.1016/j.clim.2007.09.008.PubMedCrossRef Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. IPINET. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol. 2008;126:155–64. doi:10.​1016/​j.​clim.​2007.​09.​008.PubMedCrossRef
45.
Zurück zum Zitat Casimir CM, Bu-Ghanim HN, Rodaway AR, Bentley DL, Rowe P, Segal AW. Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. Proc Natl Acad Sci USA. 1991;88:2753–57.PubMedCrossRef Casimir CM, Bu-Ghanim HN, Rodaway AR, Bentley DL, Rowe P, Segal AW. Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. Proc Natl Acad Sci USA. 1991;88:2753–57.PubMedCrossRef
Metadaten
Titel
First Report of Clinical, Functional, and Molecular Investigation of Chronic Granulomatous Disease in Nine Jordanian Families
verfasst von
Faris G. Bakri
Cécile Martel
Najwa Khuri-Bulos
Azmi Mahafzah
Mohammad S. El-Khateeb
Adel M. Al-Wahadneh
Wail A. Hayajneh
Hanan A. Hamamy
Elisabeth Maquet
Michelle Molin
Marie José Stasia
Publikationsdatum
01.03.2009
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 2/2009
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-008-9243-y

Weitere Artikel der Ausgabe 2/2009

Journal of Clinical Immunology 2/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.